New technology could help doctors make the most of limited resources during the COVID-19 pandemic by identifying patients who require intensive care unit (ICU) treatment.

The system, developed by researchers at the University of Waterloo (Waterloo, ON, Canada) and DarwinAI (Waterloo, ON, Canada), an alumni-founded startup company, uses artificial intelligence (AI) to predict the necessity of ICU admission based on more than 200 clinical data points, including vital signs, blood test results and medical history. The new AI software was trained using data from almost 400 cases at Hospital Sirio-Libanes in Sao Paulo, Brazil, in which doctors had decided if COVID patients should be admitted for intensive care.

Based on lessons learned from that known data, the neural network developed by researchers can predict the need for ICU admission in new COVID cases with greater than 95% accuracy. It also identifies the key factors that drive its predictions to help give clinicians confidence in them. Rather than replacing doctors, the technology is meant to arm them with a new tool to make faster, more informed decisions and ensure the patients most in need of intensive care receive it. The researchers have made the technology freely available so engineers and scientists around the world can work to help improve it. They are now incorporating it into a larger clinical decision support system, developed in their ongoing COVID-Net open-source initiative, that also helps doctors detect COVID and determine its severity using AI analysis of medical images.

“That is a very important step in the clinical decision support process for triaging patients and developing treatment plans,” said Alexander Wong, a professor of systems design engineering and Canada Research Chair in AI and Medical Imaging at Waterloo. “The goal is to help clinicians make faster, more consistent decisions based on past patient cases and outcomes. It’s all about augmenting their expertise to optimize the use of medical resources and individualize patient care.” 

http://www.gzjiayumed.com/en/index.asp